The Failure of Solanezumab — How the FDA Saved Taxpayers Billions
Year: 2017
Type: article
Source: New England Journal of Medicine
DOI: 10.1056/nejmp1701047
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Issues, ethics and legal aspects
Field: Nursing
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2611277309
